Evaluation of Healthcare Utilisation and Expenditures in Persons with Type 2 Diabetes Undergoing Bariatric-Metabolic Surgery.
Valerie M MonpellierRose J GeurtenIgnace M C JanssenDirk RuwaardJeroen N StruijsPeter R van DijkHenk J G BiloArianne Mathilda Josephus ElissenPublished in: Obesity surgery (2024)
BMS in people with T2DM stabilises healthcare expenditures and decreases medication use and care use for microvascular complications. In contrast, healthcare use and expenditures in T2DM patients who do not undergo surgery gradually increase over time. Due to the progressive nature of T2DM, it is expected that these differences will become larger in the long-term.
Keyphrases
- healthcare
- minimally invasive
- coronary artery bypass
- health insurance
- magnetic resonance
- glycemic control
- risk factors
- type diabetes
- palliative care
- affordable care act
- health information
- computed tomography
- skeletal muscle
- acute coronary syndrome
- adipose tissue
- gastric bypass
- percutaneous coronary intervention
- social media
- chronic pain